Hamrah, P. Et Al. 2022. Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy. Cornea , vol.41, no.6 , 673-679.

Hamrah, P., Yavuz Saricay, L., & Ozmen, M. C., (2022). Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy. Cornea , vol.41, no.6, 673-679.

Hamrah, Pedram, Leyla Yavuz Saricay, And MEHMET CÜNEYT ÖZMEN. "Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy," Cornea , vol.41, no.6, 673-679, 2022

Hamrah, Pedram Et Al. "Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy." Cornea , vol.41, no.6, pp.673-679, 2022

Hamrah, P. Yavuz Saricay, L. And Ozmen, M. C. (2022) . "Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy." Cornea , vol.41, no.6, pp.673-679.

@article{article, author={Pedram Hamrah Et Al. }, title={Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy}, journal={Cornea}, year=2022, pages={673-679} }